胡萝卜愈伤组织的诱导及细胞悬浮培养研究

分别以胡萝卜子叶、下胚轴和直根形成层为外植体诱导出愈伤组织,并建立细胞悬浮系.实验结果表明:胡萝卜下胚轴是诱导愈伤组织和进行细胞悬浮培养的理想外植体;诱导松散型愈伤组织的最佳激素浓度配比是1.0mg/L2,4 D+0.5mg/LKT;细胞悬浮培养细胞最佳起始密度为1.125×104个/mL～2.325×104个/50mL时,7d～9d为对数生长期;继代培养4代～5代时,可得到稳定的悬浮细胞系.     

DADS对人小细胞肺癌细胞株NCI—H446增殖的影响

目的探讨二烯丙基二硫（diallyldisulfide,DADS）体外抑制人肺癌细胞株NCI—H446细胞增殖作用。方法采用MTT、细胞计数、细胞活力检测DADS对体外培养的人肺癌H446细胞的抑制增殖作用;倒置显微镜观察DADS对体外培养的人肺癌H446细胞的形态学改变。结果IVIqT结果显示,DADS作用H446细胞后,明显抑制细胞增殖且抑制率呈现浓度时间依赖性关系;细胞计数结果表明,DADS作用H446细胞后其细胞群体倍增时间延长;形态学变化观察,随着DADS浓度递增,细胞逐渐稀疏,数量明显减少。结论DADS对人小细胞肺癌H446细胞株具有抗增殖作用,且与药物浓度及作用时间相关。     

种群细胞增生中一类迁移算子的谱分析

本文在Lp（1 p〈＋∞）空间上,研究了一类具年龄结构的扩散型种群细胞增生中具一般增生规律的迁移方程,讨论了这类方程相应的迁移算子的谱分析,证明了这类迁移算子本征值的存在性,并得到了该迁移算子的谱在右半平面的某区域Γ中仅由有限个具有限代数重数的离散本征值组成等结果。     

厚朴组织培养与高产细胞系建立的研究

对来自厚朴种源试验林的10个不同基因型材料开展组织培养和高产细胞系,结果表明：基本培养基、激素种类与配比、外植体的取材部位等因素对厚朴愈伤组织的诱导率、生化、褐化均有显影响。B5＋2，4-D 4mg/L NAA 1mg/L培养基的诱导率达到100％；而采用B5＋BA 1.0-2.0mg/L NAA 1.0MG/l的培养基，愈伤组织的增殖率最高，褐化率最低；140、54两个基因型的细胞增殖最快，是其它基因型细胞均值的2．12倍；不同的基因型、培养基、培养时间所产生愈伤组织细胞的厚朴酚类含量不同，以140基因型的细胞系在B5＋BA 2.0mg/L NAA 1.0mg/L的培养基上培养60d为最优。     

我国水稻生物技术研究现状

本文对近年来我国水稻生物技术诸领域，包括水稻细胞培养、原生质体培养、转基因研究及ＲＦＬＰ在育种中应用等方面的研究现状进行了综述，并对今后的发展提出了若干建议。参考文献４１篇。     

基于ANSYS的激光焊不锈钢环热传导的轴对称有限元分析

研究了焊接接头有限元数学建模；分析了激光束焊接不锈钢环应力分布规律及焊接工艺优化；结果与金相分析结果一致．     

FOXP3+调节性T细胞与免疫细胞治疗

 CD4⁺CD25⁺FOXP3⁺调节性T细胞（Treg）负责维持机体免疫稳态、调节免疫耐受。Treg细胞通过调控机体对外来或自身抗原的免疫应答水平,在抗自身免疫及抗肿瘤免疫中均发挥重要作用。深入分析了Treg细胞功能的分子机理,通过FOXP3⁺Treg细胞体外扩增或对其进行修饰改造,可以使其在不同组织及炎症微环境下特异性促进对机体的有益作用,减少副作用,这一现象会为免疫细胞治疗提供新思路与新策略。     

Haversian bone-mimicking bioceramic scaffolds enhancing MSC-macrophage osteo-imunomodulation

The interaction between immune cells and bone forming cells plays a vital role in maintaining the homeostasis of the skeletal system, and is regulated by the three-dimensional structure of tissues. Whether the construction of biomaterials can activate or reproduce this spatial “cross-talk” between immune cells and bone forming cells in bone natural formation process is a prerequisite for successful fracture healing and bone regeneration. Herein, a bone marrow mesenchymal stem cells(MSCs)/macroph...     

Is biotechnology the new alchemy?

In this article I examine similarities between the science and ethics of biotechnology on the one hand, and those of alchemy on the other, and show that the understanding of nature and naturalness upon which many contemporary ethical responses to biotechnology are predicated is, in fact, significantly similar to the understanding of nature that was the foundation of the practice of alchemy. In doing so I demonstrate that the ethical issues and social responses that are currently arising from advances in the field of biotechnology are interestingly similar to those that arose in reaction to the practice and prevalence of alchemy from its inception in Europe in the mid-twelfth century until at least the early modern period. I argue that a proper conception of the ethical issues and a sensible interpretation of the power and the promise of the science of biotechnology are most likely if we understand such attitudes to nature, and to the ethical issues surrounding technological and scientific developments, in terms of an historical and cultural continuum. That is, we should regard biotechnology as merely the latest in a string of technological and scientific developments rather than, as is often alleged, as something entirely new, requiring its own special ethical response. Finally, I suggest that examining the parallels between the ethical issues generated by alchemy and by biotechnology show us that such issues are best situated and discussed within a framework of virtue ethics, as it allows us to think seriously about the relationship between art and nature and the proper role of humans in relation to their technology.